ClinicalTrials.Veeva

Find clinical trials for Multiple Sclerosis (MS) in Toronto, ON

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near Toronto, ON, CAN:

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)

Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...

Enrolling
Multiple Sclerosis (MS)
Drug: Siponimod
Drug: Ofatumumab

Phase 3

Novartis
Novartis

Toronto, Ontario, Canada and 72 other locations

This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...

Active, not recruiting
Multiple Sclerosis
Drug: Ocrelizumab

Phase 3

Roche
Roche

Toronto, Ontario, Canada and 161 other locations

Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: Ofatumumab

Phase 3

Novartis
Novartis

Toronto, Ontario, Canada and 122 other locations

and female participants aged 18 to 60 years with relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple...

Active, not recruiting
Multiple Sclerosis
Drug: SAR443820
Other: Placebo

Phase 2

Sanofi
Sanofi

Toronto, Ontario, Canada and 40 other locations

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...

Active, not recruiting
Progressive Multiple Sclerosis (PMS)
Drug: Ocrelizumab

Phase 3

Roche
Roche

Toronto, Ontario, Canada and 125 other locations

relapse rate (ARR) in participants with relapsing forms of MSSecondary Objective:To assess efficacy of SAR442168 compared to teriflunomide (...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Placebo to match Tolebrutinib
Drug: Teriflunomide HMR1726

Phase 3

Sanofi
Sanofi

Toronto, Ontario, Canada and 177 other locations

administered orally once daily in participants with Relapsing Multiple Sclerosis (RMS). Participants who complete the double-blind ...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Evobrutinib
Drug: Placebo (match to Teriflunomide)

Phase 3

Merck KGaA (EMD Serono)
Merck KGaA (EMD Serono)

Toronto, Canada and 278 other locations

ABBV-CLS-7262 is an investigational drug being researched for the treatment of Amyotrophic Lateral Sclerosis. This is an up to 156-week, 2-p...

Active, not recruiting
Amyotrophic Lateral Sclerosis
ALS
Drug: Placebo
Drug: ABBV-CLS-7262

Phase 1

Calico Life Sciences

London, Ontario, Canada and 13 other locations

Locations recently updated

This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple...

Enrolling
Multiple Sclerosis, Primary Progressive
Drug: Ocrelizumab
Drug: Placebo

Phase 3

Roche
Roche

Toronto, Ontario, Canada and 209 other locations

A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple...

Active, not recruiting
Multiple Sclerosis, Primary Progressive
Drug: Placebo matched to ocrelizumab
Drug: Fenebrutinib

Phase 3

Roche
Roche

Toronto, Ontario, Canada and 192 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems